Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 months
Indian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs in the coming months. Approximately fifteen companies are expected to enter the primary market, with fertility and women's health segments particularly in (...)
Site référencé: The Economic Times
The Economic Times
Why is Tata Capital pricing its IPO far below unlisted levels ?
30/09/2025
SBI sees major growth in credit card business as HDFC Bank holds the top spot
30/09/2025
Trump secures Netanyahu's agreement to Gaza deal but Hamas support in question
30/09/2025
10 year bond yield jumps to 1-month high of 6.57%
30/09/2025
Bond purchases by FPIs decline in September amidst rupee weakness
30/09/2025
Post IPO, Tata Capital to have growth fuel for 3 years : CEO
30/09/2025
